Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The brain-gut-spleen axis is a complex bidirectional communication network that integrates the central nervous system, the gastrointestinal tract, and the immune system to maintain systemic homeostasis (Teratani et al., 2020, Nature). This axis primarily operates through the vagus nerve and the hypothalamic-pituitary-adrenal (HPA) axis, which transmit signals from the brain and gut to the spleen, a critical site for the regulation of systemic immunity (Bronte & Pittet, 2013, Immunity). A central component of this signaling is the "cholinergic anti-inflammatory pathway," where neural impulses in the vagus nerve trigger the release of acetylcholine in the spleen, which then binds to alpha-7 nicotinic acetylcholine receptors on macrophages to inhibit the production of pro-inflammatory cytokines like TNF-alpha (Pavlov & Tracey, 2012, Nature Reviews Endocrinology). Dysregulation of the brain-gut-spleen axis is implicated in the pathogenesis of various conditions, including inflammatory bowel disease, rheumatoid arthritis, sepsis, and certain neuropsychiatric disorders (Ji et al., 2014, Scientific Reports). While the axis itself is a physiological system rather than a single molecular target, therapeutic strategies such as bioelectronic vagus nerve stimulation and pharmacological modulation of neuroendocrine receptors are being explored to treat chronic inflammatory and autoimmune diseases (Koopman et al., 2016, PNAS).
Modulation of the cholinergic anti-inflammatory pathway via vagal efferents and the hypothalamic-pituitary-adrenal (HPA) axis to regulate splenic cytokine production and systemic immune homeostasis.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Brain-gut-spleen axis (BGSA).